Skip to main content

Table 4 Best Response in all evaluable patients

From: A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker

ID

Cohort

Best Responsea

Days on Study

1

1

PD

43

2

SD

124

3

PD

32

4

2

PD

40

5

PD

55

6

PD

26

7

3

SD

42

8

PD

56

10

4

PD

56

11

SD

109

12

PD

28

13

SD

109

14

PD

34

15

PD

43

16

PD

56

  1. aPD progressive disease, NA not available
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us